EDX Medical Group (AQSE:EDX) Capital Expenditure : £0.00 Mil (TTM As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is EDX Medical Group Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

EDX Medical Group's cash flow for capital expenditures for the six months ended in . 20 was £0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in . 20 was £0.00 Mil.

EDX Medical Group Capital Expenditure Historical Data

The historical data trend for EDX Medical Group's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EDX Medical Group Capital Expenditure Chart

EDX Medical Group Annual Data

Trend

Capital Expenditure

EDX Medical Group Semi-Annual Data

Capital Expenditure

EDX Medical Group Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Capital Expenditure for the trailing twelve months (TTM) ended in . 20 was £0.00 Mil.

EDX Medical Group (AQSE:EDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » EDX Medical Group PLC (AQSE:EDX) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

N/A

Address

210-211 Milton Road, Cambridge, GBR, CB4 0WA

Website

https://edxmedical.co.uk

EDX Medical Group Plc develops and validates digitally enabled diagnostic products and services to help predict disease risk, inform clinical decision-making and accelerate the development of new medicines in the areas of cancer, heart disease, neurology and infectious diseases.

EDX Medical Group (AQSE:EDX) Headlines

No Headlines